We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Actividentity Corp (MM) | NASDAQ:ACTI | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.24 | 0 | 01:00:00 |
Laquinimod
ANYARA
Tasquinimod, Paquinimod and SILC
New share issue
Financial summary
SEK M | Oct - Dec | Jan - Dec | ||
2016 | 2015 | 2016 | 2015 | |
Net sales | 7.1 | 5.0 | 19.0 | 16.3 |
Operating loss | -13.5 | -28.2 | -55.1 | -177.9 |
Loss for the period | -14.8 | -40.8 | -59.6 | -193.5 |
Loss per share, before and after dilution (SEK) | -0.16 | -0.45 | -0.65 | -2.13 |
Cash and cash equivalents | 77.7 | 103.6 | ||
For further information, please contact:
Tomas Leanderson, President and CEO Tel: +46 (0) 46 19 20 95 Hans Kolam, CFO Tel: +46 (0)46 19 20 44 | Active Biotech AB (Corp. Reg. No. 556223-9227) Box 724, SE-220 07 Lund Tel: +46 (0)46-19 20 00 |
The report is also available at www.activebiotech.com.
1 Year Actividentity Corp (MM) Chart |
1 Month Actividentity Corp (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions